Pancreatic Cancer Research

ResearcherJikei University School of MedicineNo recent work listed

Hiroshi Sugano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1138-0876; OpenAlex author ID A5035899193. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Thrombomodulin expression impacts the recurrence and long-term survival in pancreatic cancer. Co-author DOI 10.1002/ags3.12447↗
  2. Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo. Co-author DOI 10.18632/oncotarget.24608↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshihiro Shirai · 2 shared papers, 2018–2021 · strength 0.21
  2. Takashi Horiuchi · 2 shared papers, 2018–2021 · strength 0.21
  3. Toru Ikegami · 1 shared paper, 2021 · strength 0.13
  4. Tomohiko Taniai · 1 shared paper, 2021 · strength 0.13
  5. Takeshi Gocho · 1 shared paper, 2021 · strength 0.13
  6. Ryoga Hamura · 1 shared paper, 2021 · strength 0.13
  7. Nobuhiro Saito · 1 shared paper, 2018 · strength 0.08
  8. Koichiro Haruki · 1 shared paper, 2018 · strength 0.08
  9. Hiroaki Shiba · 1 shared paper, 2018 · strength 0.08
  10. Tadashi Uwagawa · 1 shared paper, 2018 · strength 0.08
  11. Katsuhiko K. Yanaga · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.